Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. PLx Pharma, Inc. market cap is $8.21M.
What is the 52-week high for PLx Pharma, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. PLx Pharma, Inc. 52 week high is $142.01 as of October 26, 2025.
What is the 52-week low for PLx Pharma, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. PLx Pharma, Inc. 52 week low is $1.34 as of October 26, 2025.
What is PLx Pharma, Inc. stock price today?
PLx Pharma, Inc. stock price today is $1.34.
What is the PE ratio of PLx Pharma, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. PLx Pharma, Inc.’s P/E ratio is None.
What is the Price-to-Book ratio of PLx Pharma, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. PLx Pharma, Inc. P/B ratio is 0.5810.
What is PLx Pharma, Inc.'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. PLx Pharma, Inc.'s EBITDA is -0.12.
What is the 50-day moving average of PLx Pharma, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. PLx Pharma, Inc. 50-day moving average is $7.97.
